Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients.

Skip to main content

Open Access Publications from the University of California

Thiazolidinedione use is associated with improved all-cause mortality compared with sulfonylureas among diabetic hemodialysis patients.

2014

Author(s): Lynch, Katherine E;
Rhee, Connie M;
Brunelli, Steven M
et al.

Published Web Location

https://doi.org/10.1111/1753-0407.12115

Creative Commons 'BY' version 4.0 license

Main Content

For improved accessibility of PDF content, download the file to your device.